Citigroup
HPTX

Citigroup’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Citigroup’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,465
Closed -$160K – 8092
2015
Q1 		$160K Sell
3,465
-3,203
-48% -$95.8K ﹤0.01% 4716
2014
Q4 		$160K Buy
6,668
+6,195
+1,310% +$140K ﹤0.01% 4875
2014
Q3 		$12K Buy
473
+358
+311% +$8.89K ﹤0.01% 6200
2014
Q2 		$3K Sell
115
-1,184
-91% -$30.4K ﹤0.01% 6696
2014
Q1 		$34K Sell
1,299
-1,493
-53% -$40.5K ﹤0.01% 5742
2013
Q4 		$56K Sell
2,792
-1,175
-30% -$27.7K ﹤0.01% 5665
2013
Q3 		$104K Buy
3,967
+1,888
+91% +$47.3K ﹤0.01% 4690
2013
Q2 		$45K Buy
+2,079
New +$45.5K ﹤0.01% 5437

Citigroup's HPTX Position: Q2 2015 in Review

Citigroup sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 3,465 shares — an estimated $160K sold.

Citigroup first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $160K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Citigroup reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Citigroup sold 3,465 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $160K.
  • Citigroup first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Citigroup's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $160K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.